Xanthine compounds and method of treating bronchospastic and all

Details Xanthine compounds and method of treating bronchospastic and all Xanthine compounds and method of treating bronchospastic and all

1976-03-31

1978-10-17

Schenkman, Leonard

Drug, bio-affecting and body treating compositions

Effervescent or pressurized fluid containing

Organic pressurized fluid

424253, 544271, 544273, 544311, 544312, C07D47306, A61K 3152

Patent

active

041209478

ABSTRACT:
Bronchial asthma and other bronchospastic and allergic diseases are treated by administering an effective amount of a substituted xanthine compound having the formula: ##STR1## wherein: R.sub.1 = C.sub.1 -C.sub.3 alkyl,

REFERENCES:
patent: 2729643 (1956-01-01), Stoll et al.
patent: 3632742 (1972-01-01), Eckert et al.
Cutting, handbook of Pharmacology, 4th Edition, pp. 294-296.
Giari et al. - II Farmaco-Ed. Sc. 12(12): 1016-1024, (1957).
Vieth et al. - Biochem. Zeitschr. 163, 13-26, (1925).

Affiliated with

Also associated with

Rating

Xanthine compounds and method of treating bronchospastic and all does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Xanthine compounds and method of treating bronchospastic and all, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Xanthine compounds and method of treating bronchospastic and all will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-375806